{"retracted":false,"update":{"timestamp":1484611200000,"doi":"10.1080/02652048.2017.1281207","type":"correction"},"doi":"10.1080/02652048.2016.1222005","journal":"Journal of Microencapsulation","publisher":"Informa UK Limited","title":"Correction to: Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part I. Albumin-bound betulinic acid nanoparticles (ABBns)"}
